Reporter : Long Hua ; Correspondent : Huang Shan
Publisher : Hubei Daily; Reproduced on Henan Daily
Ref : https://www.henandaily.cn/content/2020/0505/229069.html
Translation, editing : Gan Yung Chyan
/ KUCINTA SETIA
Image : At a Wuhan hospital. Video Screenshot.
According to the provincial medical security bureau of Hubei on 5 May 2020, payments for the novel coronavirus nucleic acid and antibody tests will be covered temporarily throughout the province from 6 May 2020 by the provincial basic medical insurance diagnosis and treatment catalogue according to Category B.
It is reported that nucleic acid and antibody testing items are included in the medical insurance payment. The specific standards for medical insurance payment are determined by localities based on local actual conditions, but not higher than the previous maximum price of 180 yuan per nucleic acid testing and 50 yuan per antibody testing in the province. Dynamic adjustments are allowed.
According to the provincial medical insurance bureau, new medical service items are usually included in the medical insurance catalogue, and they can only be included after a series of processes such as application, preliminary review, expert review, publicity, and approval according to the principle of "necessary clinical diagnosis and treatment, safe and effective, and appropriate cost". Medical insurance payment scope. In order to ensure the timely treatment of patients with novel coronavirus pneumonia, at the beginning of the outbreak, Hubei took the lead in clearly including the cost of nucleic acid testing and antibody testing for confirmed and suspected patients during treatment in medical institutions. Since then, it has initiated the centralized procurement of novel coronavirus-related detection reagents and set the maximum price for nucleic acid detection and antibody detection in the province. This time, according to the principle of special affairs, the relevant test items were temporarily included in the medical insurance catalogue. During the epidemic situation, the current medical insurance policy regulations will be implemented.
StayGate's Notes:
The above inclusions of nucleic acid and antibody tests in Hubei medical insurance coverage suggest the covid epidemic in Hubei is not over. The People's Republic of China is still concealing the epidemic situation in Hubei.
Publisher : Hubei Daily; Reproduced on Henan Daily
Ref : https://www.henandaily.cn/content/2020/0505/229069.html
Translation, editing : Gan Yung Chyan
/ KUCINTA SETIA
Image : At a Wuhan hospital. Video Screenshot.
According to the provincial medical security bureau of Hubei on 5 May 2020, payments for the novel coronavirus nucleic acid and antibody tests will be covered temporarily throughout the province from 6 May 2020 by the provincial basic medical insurance diagnosis and treatment catalogue according to Category B.
It is reported that nucleic acid and antibody testing items are included in the medical insurance payment. The specific standards for medical insurance payment are determined by localities based on local actual conditions, but not higher than the previous maximum price of 180 yuan per nucleic acid testing and 50 yuan per antibody testing in the province. Dynamic adjustments are allowed.
According to the provincial medical insurance bureau, new medical service items are usually included in the medical insurance catalogue, and they can only be included after a series of processes such as application, preliminary review, expert review, publicity, and approval according to the principle of "necessary clinical diagnosis and treatment, safe and effective, and appropriate cost". Medical insurance payment scope. In order to ensure the timely treatment of patients with novel coronavirus pneumonia, at the beginning of the outbreak, Hubei took the lead in clearly including the cost of nucleic acid testing and antibody testing for confirmed and suspected patients during treatment in medical institutions. Since then, it has initiated the centralized procurement of novel coronavirus-related detection reagents and set the maximum price for nucleic acid detection and antibody detection in the province. This time, according to the principle of special affairs, the relevant test items were temporarily included in the medical insurance catalogue. During the epidemic situation, the current medical insurance policy regulations will be implemented.
StayGate's Notes:
The above inclusions of nucleic acid and antibody tests in Hubei medical insurance coverage suggest the covid epidemic in Hubei is not over. The People's Republic of China is still concealing the epidemic situation in Hubei.
No comments:
Post a Comment